BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9589382)

  • 1. Noncompetitive inhibition of nicotinic acetylcholine receptors by endogenous molecules.
    Arias HR
    J Neurosci Res; 1998 May; 52(4):369-79. PubMed ID: 9589382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding sites for exogenous and endogenous non-competitive inhibitors of the nicotinic acetylcholine receptor.
    Arias HR
    Biochim Biophys Acta; 1998 Aug; 1376(2):173-220. PubMed ID: 9748559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topology of ligand binding sites on the nicotinic acetylcholine receptor.
    Arias HR
    Brain Res Brain Res Rev; 1997 Oct; 25(2):133-91. PubMed ID: 9403137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Doxylstearate-induced displacement of phencyclidine from its low-affinity binding sites on the nicotinic acetylcholine receptor.
    Arias HR
    Arch Biochem Biophys; 1999 Nov; 371(1):89-97. PubMed ID: 10525293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonist self-inhibitory binding site of the nicotinic acetylcholine receptor.
    Arias HR
    J Neurosci Res; 1996 Apr; 44(2):97-105. PubMed ID: 8723217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Luminal and non-luminal non-competitive inhibitor binding sites on the nicotinic acetylcholine receptor.
    Arias HR
    Mol Membr Biol; 1996; 13(1):1-17. PubMed ID: 9147657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinacrine and ethidium bromide bind the same locus on the nicotinic acetylcholine receptor from Torpedo californica.
    Lurtz MM; Hareland ML; Pedersen SE
    Biochemistry; 1997 Feb; 36(8):2068-75. PubMed ID: 9047305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temperature and ionic strength dependence of quinacrine binding and quinacrine displacement elicited by high concentrations of agonists on the nicotinic acetylcholine receptor.
    Arias HR
    Arch Biochem Biophys; 1996 Sep; 333(1):1-11. PubMed ID: 8806747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of agonist and competitive antagonist binding sites on nicotinic acetylcholine receptors.
    Arias HR
    Neurochem Int; 2000 Jun; 36(7):595-645. PubMed ID: 10771117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of local anesthetics on both cholinergic and serotonergic ionotropic receptors.
    Arias HR
    Neurosci Biobehav Rev; 1999; 23(6):817-43. PubMed ID: 10541058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The high-affinity quinacrine binding site is located at a non-annular lipid domain of the nicotinic acetylcholine receptor.
    Arias HR
    Biochim Biophys Acta; 1997 Jul; 1347(1):9-22. PubMed ID: 9233683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of lipids and ligands with nicotinic acetylcholine receptor vesicles assessed by electron paramagnetic resonance spectroscopy.
    Arias HR
    Methods Mol Biol; 2010; 606():291-318. PubMed ID: 20013404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive and negative modulation of nicotinic receptors.
    Arias HR
    Adv Protein Chem Struct Biol; 2010; 80():153-203. PubMed ID: 21109220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The steroid promegestone is a noncompetitive antagonist of the Torpedo nicotinic acetylcholine receptor that interacts with the lipid-protein interface.
    Blanton MP; Xie Y; Dangott LJ; Cohen JB
    Mol Pharmacol; 1999 Feb; 55(2):269-78. PubMed ID: 9927618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the dizocilpine binding site on the nicotinic acetylcholine receptor.
    Arias HR; McCardy EA; Blanton MP
    Mol Pharmacol; 2001 May; 59(5):1051-60. PubMed ID: 11306687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of interaction of 3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester with Torpedo californica nicotinic acetylcholine receptor and 5-hydroxytryptamine3 receptor.
    Sun H; McCardy EA; Machu TK; Blanton MP
    J Pharmacol Exp Ther; 1999 Jul; 290(1):129-35. PubMed ID: 10381768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noncompetitive antagonist binding sites in the torpedo nicotinic acetylcholine receptor ion channel. Structure-activity relationship studies using adamantane derivatives.
    Arias HR; Trudell JR; Bayer EZ; Hester B; McCardy EA; Blanton MP
    Biochemistry; 2003 Jun; 42(24):7358-70. PubMed ID: 12809491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms and binding site locations for noncompetitive antagonists of nicotinic acetylcholine receptors.
    Arias HR; Bhumireddy P; Bouzat C
    Int J Biochem Cell Biol; 2006; 38(8):1254-76. PubMed ID: 16520081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockage of mouse muscle nicotinic receptors by serotonergic compounds.
    GarcĂ­a-Colunga J; Miledi R
    Exp Physiol; 1999 Sep; 84(5):847-64. PubMed ID: 10502654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist-induced displacement of quinacrine from its binding site on the nicotinic acetylcholine receptor: plausible agonist membrane partitioning mechanism.
    Arias HR
    Mol Membr Biol; 1995; 12(4):339-47. PubMed ID: 8747279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.